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Development of the CRISPR/Cas9 System for Targeted Gene
Disruption in Aspergillus fumigatus
Kevin K. Fuller,a Shan Chen,a Jennifer J. Loros,b Jay C. Dunlapa
Department of Genetics, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USAa; Department of Biochemistry, Geisel School of Medicine at Dartmouth,
Hanover, New Hampshire, USAb
Low rates of homologous recombination have broadly encumbered genetic studies in the fungal pathogen Aspergillus fumigatus.
The CRISPR/Cas9 system of bacteria has recently been developed for targeted mutagenesis of eukaryotic genomes with high effi-
ciency and, importantly, through a mechanism independent of homologous repair machinery. As this new technology has not
been developed for use in A. fumigatus, we sought to test its feasibility for targeted gene disruption in this organism. As a proof
of principle, we first demonstrated that CRISPR/Cas9 can indeed be used for high-efficiency (25 to 53%) targeting of the A. fu-
migatus polyketide synthase gene (pksP), as evidenced by the generation of colorless (albino) mutants harboring the expected
genomic alteration. We further demonstrated that the constitutive expression of the Cas9 nuclease by itself is not deleterious to
A. fumigatus growth or virulence, thus making the CRISPR system compatible with studies involved in pathogenesis. Taken to-
gether, these data demonstrate that CRISPR can be utilized for loss-of-function studies in A. fumigatus and has the potential to
bolster the genetic toolbox for this important pathogen.
Aspergillus fumigatus is a ubiquitous saprophytic fungus thatplays an essential role in carbon and nitrogen recycling within
ecosystems but is also a major cause of disease in immunocom-
promised individuals (1, 2). Over the past several decades, the
incidence of invasive aspergillosis has risen along with the suscep-
tible patient population, thus highlighting the need for a better
understanding of virulence determinants in the fungus (3–5). The
most powerful approach in this regard remains the generation and
analysis of mutants. Randomized UV or insertional mutagenesis
screens have been used on a limited basis to identify essential genes
(6) as well as novel pigmentation (7) and drug-resistant mutants
(8). However, due to the growing comparative genomic and bio-
logical data from other fungi, the major approach in recent years
has by far been that of reverse genetics, involving the targeted
disruption of candidate genes.
The major limitation for gene deletion in A. fumigatus, and
indeed most filamentous fungi, has been the relatively low rates
of homologous recombination, reported as lower than 5% de-
pending on the gene (9). This is due largely to the presence of
nonhomologous end joining (NHEJ) systems that preferentially
promote the ectopic insertion of the targeting DNA. The high
false-negative ratios among transformants, coupled with labori-
ous and often low-yield transformation techniques (e.g., chemical
transformation of protoplasts), may necessitate the screening of
hundreds of transformants across multiple transformation at-
tempts before the desired mutant is isolated. Consequently, sev-
eral groups have developedA. fumigatus recipient strains in which
the NHEJ pathway (ku70 orku80) is disabled, allowing homol-
ogous recombination to occur at a higher frequency among trans-
formants (9, 10). Newer and more elegant methods, such as the
hygromycin resistance split-marker approach, where fragments of
a selectable marker must recombine homologously in order to
confer drug resistance, further increase the probability of obtain-
ing the desired mutant (11).
Another limiting factor for mutagenesis in A. fumigatus stems
from the restricted number of dominant selectable markers, of
which there are three predominantly employed: the hygromycin
phosphotransferase gene (hph) for hygromycin selection, ble for
phleomycin resistance, and ptrA for pyrithiamine selection.
Therefore, work in wild-type (i.e., prototrophic) backgrounds
permits the deletions of only three genes, which are performed in
successive transformations. Several auxotrophic strains have been
employed by the community, including adeA, adeB, argB, niaD,
pyrG, pyrE, sC, and trpC. A limitation of using such strains, how-
ever, is the loss of virulence observed in some of the strains, e.g.,
pyrG strains (12); thus, proper isogenic controls for virulence ex-
periments may be lacking.
Finally, the need for homologous genomic targeting may be
bypassed by gene silencing with RNA interference (RNAi).
Whereas this method provides an advantage of targeting multiple
gene products, a complete loss of target gene expression has never
been achieved in this system (13, 14).
A more recent alternative to homologous repair-based tech-
niques is the clustered, regularly interspaced, short palindromic
repeat (CRISPR) technology utilizing an RNA-guided nuclease,
CRISPR-associated (Cas9) protein. CRISPR/Cas9 originates as a
prokaryotic adaptive defense system against invading viruses and
DNA (15, 16). Remarkably, and in just the past 2 years, the system
derived from Streptococcus pyogenes (17) has been simplified as a
genomic engineering tool in diverse eukaryotes, such as mice and
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rats (18–21), plants (22, 23), and even fungi, including Saccharo-
myces cerevisiae (24), Candida albicans (25), Trichoderma reesei
(26), and other Aspergillus spp. (27). Briefly, a synthetic single-
guide RNA (gRNA), which is a fusion of CRISPR RNA (crRNA)
and trans-activating crRNA (tracrRNA), associates with endonu-
clease Cas9 and guides it to a 20-nucleotide genomic target. When
the genomic target is adjacent to a Cas9-specific protospacer-ad-
jacent motif (PAM), 5=-NGG, Cas9 will induce a double-strand
DNA break (17, 28, 29). Indel mutagenesis occurs through NHEJ
in genomic targets, inducing frameshifts and resulting in nonsense
mutations or otherwise nonfunctional proteins. For the CRISPR/
Cas9 system in yeast it has been reported that through short NHEJ-
mediated indels, there is a 469-fold increase in mutation frequency
for target gene disruption after cas9 gene induction (24). Moreover,
the simultaneous targeting of multiple loci can be achieved by intro-
ducing multiple and unique gRNA sequences (18, 26).
In summary, the CRISPR/Cas9 system provides the benefits of
RNAi in that it bypasses the need for homologous recombination and
allows for the targeting of multiple genes in a single transformation;
however, it is perhaps more attractive than RNAi in that it works at
the genomic level, making gene silencing complete and stable. In this
report, we demonstrate that CRISPR/Cas9 can be used for high-effi-
ciency gene disruption in A. fumigatus, using the pksP gene (essen-
tial for melanin production) as a case study (30, 31). We also
demonstrate that constitutive expression of Cas9 alone does not
alter growth rate, development, resistance to oxidative stress, cell
wall homeostasis, antifungal sensitivity, or virulence in a murine
model. This, importantly, establishes that A. fumigatus mutants
generated with CRISPR/Cas9 are compatible for pathogenesis
studies. In addition, we describe an NHEJ-mediated integration of
transforming DNA to the Cas9 cut site, a phenomenon that, to our
knowledge, has not been described in other fungal CRISPR sys-
tems.
MATERIALS AND METHODS
Vector construction and transformation intoA. fumigatus.All PCRs for
vector construction were performed with Phusion Flash DNA polymerase
(Thermo Fisher) unless otherwise noted. All primer sequences are listed in
Table S1 in the supplemental material.
(i) p-hph-Ptef1-cas9-pksP-gRNA for introduction into wild-type A.
fumigatus. The hygromycin phosphotransferase (hph) cassette was am-
plified from pAN7-1 using primers 1 and 2. The Ptef1-cas9 cassette was
amplified from p414-TEF1p-Cas9-CYC1t (Addgene plasmid 43802) with
primers 3 and 4. The pksP-gRNA cassette was generated across three
PCRs: (i) the SNR52 promoter was amplified from p426-SNR52p-
gRNA.CAN1.Y-SUP4t (Addgene plasmid 43803) with primers 5 and 6,
(ii) the pksP-gRNA was amplified from p426-SNR52p-gRNA.CAN1.Y-
SUP4t using primers 7 and 8, and (iii) the SNR52 promoter and pksP-
gRNA fragments were fused in an overlap PCR using primers 5 and 8.
Finally, the hph, cas9, and pksP-gRNA fragments were assembled and
cloned into pRS426 by homologous recombination within S. cerevisiae
cells (32). Yeast clones were screened by PCR, and the desired p-hph-
Ptef1-cas9-pksP-gRNA was purified. The purified plasmid was used as a
template for PCR using primers 1 and 8, and the resulting hph-cas9-gRNA
product was introduced into Af293 protoplasts as described below.
(ii) p-bleR-pksPgRNA for introduction into cas9-hph strains. The
bleR cassette was amplified from pBC-phleo (33) using primers 11 and 12.
The pksP-gRNA cassette was generated across three PCRs: (i) the SNR52
promoter was amplified from p426-SNR52p-gRNA.CAN1.Y-SUP4t with
primers 13 and 6, (ii) the pksP-gRNA was amplified from p426-SNR52p-
gRNA.CAN1.Y-SUP4t using primers 7 and 14, and (iii) the SNR52 pro-
moter and pksP-gRNA fragments were fused in an overlap PCR using
primers 13 and 14. Finally, the bleR and pksP-gRNA fragments were fused
in an overlap PCR using primers 11 and 14, and the overlap product was
cloned into pSC-amp/kan (Strataclone). The p-bleR-pksP-gRNA plasmid
was linearized with KpnI restriction endonuclease and introduced into
either the Af293 or CEA10 cas9-hph strain by chemical transformation as
described below.
(iii) p-hph-pksP-gRNA for transformation into wild-type A. fu-
migatus. The hph cassette was amplified with primers 1 and 20. The pksP-
gRNA cassette was generated across three PCRs: (i) the SNR52 promoter
was amplified from p426-SNR52p-gRNA.CAN1.Y-SUP4t with primers
21 and 6, (ii) the pksP-gRNA was amplified from p426-SNR52p-
gRNA.CAN1.Y-SUP4t using primers 7 and 8, and (iii) the SNR52 pro-
moter and pksP-gRNA fragments were fused in an overlap PCR using
primers 21 and 8. Finally, the hph and pksP-gRNA fragments were assem-
bled and cloned into pRS426 by homologous recombination within S.
cerevisiae cells. The resulting p-hph-pksP-gRNA plasmid was used as a
template for PCR using primers 1 and 8. The resulting product was intro-
duced into Af293 wild-type protoplasts as described below.
Chemical transformation of A. fumigatus protoplasts. Transforma-
tion of A. fumigatus protoplasts was performed as described previously
(34) with some modification. Briefly, conidia were incubated in glucose min-
imal medium (GMM) (1% glucose, 10 mM ammonium tartrate, salts, pH
6.5) supplemented with 0.5% yeast extract for 10 h at 30°C. Following incu-
bation, the cell wall of germlings was digested with 3.5 mg/ml lysing enzymes
(Sigma, L1412) for 5 h at 28°C. Protoplasts were transformed with10 g
DNA using 60% polyethylene glycol (PEG) 3350 (Sigma-Aldrich) and plated
onto GMM supplemented with 1.2 M sorbitol. Following 24 h of incubation
at room temperature, plates were overlaid with top agar containing hygromy-
cin or phleomycin and subsequently incubated at 37°C.
A. fumigatus strains used for this study. The wild-type A. fumigatus
strain Af293 was obtained from Judith C. Rhodes at the University of
Cincinnati, and the wild-type CEA10 and pksP mutant (Af293 back-
ground) were obtained from Robert A. Cramer, Jr., at Dartmouth.
For construction of the cas9-hph strains, the hph-cas9 fragment was
amplified from the p-hph-Ptef1-cas9-pksP-gRNA plasmid (see above) us-
ing primers 9 and 10. The PCR product was then introduced into wild-
type Af293 or CEA10 protoplasts by chemical transformation as described
above. Integration of the cas9 gene into transformants was initially deter-
mined by PCR of gDNA with primers 3 and 4, followed by Southern
blotting (described below).
Southern blotting. The number of sites into which the cas9 gene was
integrated in Af293 or CEA10 recipient strains was analyzed by Southern
blotting using the digoxigenin (DIG) system (Roche). Briefly, 40 g of
genomic DNA was digested in a BamHI and NcoI double digestion in buffer
3.1 (New England BioLabs) overnight at 37°C and then electrophoresed in a
1% Tris-acetate-EDTA (TAE) agarose gel at 50 V for 2 h. The gel was trans-
ferred onto a positively charged nylon membrane (Roche) via capillary trans-
fer overnight in 20SSC buffer (1SSC is 0.15 M NaCl plus 0.015 M sodium
citrate). The membrane was hybridized overnight at 42°C with 200 ng/ml of a
2.4-kb DIG probe (Roche) targeted to the cas9 gene (see Fig. S1A in the
supplemental material). The probe was stained with anti-DIG–alkaline phos-
phatase (AP) antibody (Roche) and visualized with chemiluminescent CDP-
Star (Roche) according to the manufacturer’s instructions. The membrane
was exposed to a chemiluminescent X-ray film (GE Healthcare) for 1 to 2 min
to visualize bands.
Western blotting. The expression of Cas9 in the cas9-hph strains was
analyzed by Western blotting. Briefly, overnight 37°C liquid cultures of recip-
ient strains were collected, lyophilized, and mechanically broken using
3.5-mm steel beads in protein extraction buffer (50 mM Tris-HCl [pH 7.5],
0.1 M EDTA, 1 mM -mercaptoethanol) and protease inhibitor (Pierce) for
2 min. The slurry was incubated on ice for 10 min, and then the supernatant
was collected after centrifugation at 4°C. The protein amount was determined
by the Bradford method using protein assay dye reagent concentrate (Bio-
Rad). Twenty micrograms of protein was loaded into a 3 to 8% Tris-acetate
polyacrylamide gel and wet transferred to a polyvinylidene difluoride (PVDF)
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membrane (Millipore). The membrane was stained with a 1:500 dilution of
anti-Cas9 monoclonal antibody (Epigentek), washed, and then stained with a
1:3,000 dilution of anti-mouse IgG horseradish peroxidase (HRP)-conju-
gated antibody (Bio-Rad). The membrane was visualized with SuperSignal
West Pico chemiluminescent substrate (Thermo Scientific) according to the
manufacturer’s instructions and exposed to a chemiluminescence-sensitive
X-ray film (GE Healthcare) for 1 to 2 min.
Reverse transcription-PCR (RT-PCR) analysis. Conidia of the wild-
type and cas9-hph strains were incubated in GMM (supplemented with
0.5% yeast extract) overnight at 37°C. Tissue was harvested by brief vac-
uum filtration and then frozen with liquid nitrogen. RNA was isolated by
crushing the frozen tissue with a glass rod and processing the powder with
an RNeasy kit (Qiagen). Two micrograms of RNA was used for first-
strand synthesis (Superscript III; Invitrogen), and 1 l of cDNA was used
in a 20-l PCR mixture using primers 15 and 16.
Sequencing of the target locus in transformant colonies. The coding
sequence of pksP (Afu2g17600) was amplified from each of the strains
using Phusion Flash DNA polymerase and primers 17 and 18 and then
cleaned using a PCR purification kit (Qiagen). The 1.3-kb region sur-
rounding the gRNA cut site was sequenced at the Molecular Biology Core
at Dartmouth using primer 19.
Growth rate and stress resistance assays. To assess the radial growth
rate, 2 l of a 5  106 ml1 conidial suspension of the indicated strains
was point inoculated onto the center of a GMM plate. Plates were incu-
bated for 72 h at 37°C.
For the stress tolerance assays, 2l of a 5 106 ml1 conidial suspen-
sion was point inoculated onto GMM containing the indicated drug.
Plates were incubated for 48 h at 37°C.
Virulence determination. All animal experiments were approved by
the Institutional Animal Care and Use Committee at Dartmouth College.
Groups of female CD-1 mice (Charles River Laboratories) were injected
subcutaneously with 40 mg/kg of triamcinolone acetonide (Kenalog-10;
Bristol-Meyers Squibb). On the following day (day 0), animals were anes-
thetized in an isoflurane chamber and inoculated intranasally with fungal
conidia suspended in 25 l phosphate-buffered saline (PBS); Af293 ani-
mals received 1.0  106 conidia, whereas CEA10 animals received 5.0 
105 conidia. The Af293 animals (both wild type and cas9-hph) received a
second 40-mg/kg injection on day 3. Moribund animals were eutha-
nized by CO2 asphyxiation. Mortality curves for the wild-type- and cas9-
hph-infected groups were compared by the log rank test.
Quantitation of conidiation. A 120-l portion of a 1.0  106 ml1
conidial suspension was plated across 15-mm GMM agar plates and in-
cubated for either two (Af293 background) or three (CEA10 back-
ground) days at 37°C. Following incubation, conidia were harvested by
swabbing conidia into 10 ml of sterile water, and this was repeated
three times (40 ml total). Conidial suspensions were diluted and sub-
sequently enumerated with a hemacytometer. Three plates were ana-
lyzed per group.
RESULTS
Targeted disruption of pksP in wild-type A. fumigatus using
CRISPR/Cas9. Our overall goal was to assess the feasibility of
using the CRISPR/Cas9 system for targeted gene disruption in A.
fumigatus. As a proof of principle, we chose to target the pksP gene
(AFUA_2G17600), encoding a polyketide synthase essential in the
synthesis of dihydroxynaphthalene (DHN) melanin. In contrast
to wild-type A. fumigatus colonies, which appear green due to the
production of melanized conidia, pksP mutants appear com-
pletely white (albino) (30, 31). Accordingly, the successful disrup-
tion of pksP could be determined simply by the presence of albino
transformants, and the overall targeting efficiency could be dis-
cerned from the phenotypic ratios.
The target gRNA sequence was designed based on criteria that
had proved successful in S. cerevisiae (24). First, we searched for
PAM sites (-NGG) that existed within an exon and approximately
100 to 200 nucleotides downstream of the pksP translational start.
The 13-nucleotide sequence directly upstream of each PAM site
(i.e., the seed sequence) was used in a BLAST analysis against the
A. fumigatusAf293 genome; those that lacked complete identity to
another locus were considered candidate gRNA targets. Three
sites emerged based on these criteria, the most ATG proximal of
which was selected for our studies (Fig. 1).
We first generated a vector that, following random integration
into the genome, would allow for pksP targeting in wild-type A.
fumigatus (Fig. 2A). The construct consisted of three components:
(i) Ptef1-cas9, in which the cas9 nuclease gene, used previously in
S. cerevisiae (codon optimized for use in human cells), is driven by
FIG 1 Diagram of the pksP-targeting Cas9/gRNA complex. The illustration shows the pksP-specific guide RNA (gRNA) used in this study associating with the
Cas9 endonuclease. The locations of the protospacer-adjacent motif (PAM), Cas9 double-strand cut site (3 to 4 nucleotides upstream of the PAM site), and other
candidate gRNAs within the first exon are shown (green).
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the tef1 promoter; (ii) pksP-gRNA, consisting of the above-de-
scribed pksP target sequence fused with the structural gRNA ele-
ment; and (iii) the hygromycin phosphotransferase gene (hph) for
the positive selection of transformants. Following the fusion and
cloning of the three cassettes via yeast recombination, the hph-
cas9-gRNA insert was PCR amplified and introduced into A. fu-
migatus (strain Af293) protoplasts by chemical transformation.
Two independent transformations yielded a total of 98 hygromy-
cin-resistant colonies, which were subcultured onto GMM plates
and incubated for 72 h at 37°C to assess their phenotype. Remark-
ably, 52 transformants (53%) resembled thepksP control strain,
whereas the remaining colonies were indistinguishable from the
wild type (Fig. 2B and C), indicating that the CRISPR/Cas9 system
can indeed function in A. fumigatus with high efficiency.
Because the gRNA portion hph-cas9-gRNA cassette contains
homology to the genomic target, albeit across a small region (20
bp), we wanted to exclude the possibility that pksP disruption was
due to a homologous recombination event. Accordingly, con-
structs containing the pksP-gRNA alone (gRNA-hph) or the cas9
gene alone (cas9-hph) were generated and introduced into Af293
wild-type protoplasts. Whereas albino transformants were gener-
ated from the hph-cas9-gRNA construct, all hygromycin-resistant
colonies derived from the gRNA-hph or the cas9-hph transforma-
tions resembled the wild type (see Fig. S1 in the supplemental
material). This suggested that both the cas9 gene and the pksP-
gRNA are essential components for pksP targeting in our system
and that the contribution of homologous recombination alone is
negligible.
Effect of constitutive cas9 expressiononA. fumigatus growth
and virulence. If mutants generated with the CRISPR system are
to be useful for pathogenesis studies, it is imperative that expres-
sion of the cas9 nuclease itself is not deleterious with respect to A.
fumigatus growth or virulence. We sought to test this by generat-
ing strains that constitutively express cas9 without the presence of
a targeting gRNA. To do so, the Ptef1-cas9 cassette (described
above) was fused with the hph marker, and the resulting construct
(the same used in the control transformation described above)
was introduced into the two most commonly employed A. fu-
migatus strains, Af293 and CEA10 (Fig. 3A). The integration of
cas9 into the genome of hygromycin-resistant colonies was first
tested by PCR (data not shown) and then confirmed by Southern
blotting (see Fig. S2A in the supplemental material). The expres-
sion of cas9was subsequently confirmed by both Western blot (see
Fig. S2B in the supplemental material) and RT-PCR (Fig. 3A)
analyses. The colonial appearance of all cas9-expressing transfor-
mants (called cas9-hph) was identical to that of the respective
Af293 or CEA10 recipient strain. A single isolate in either back-
ground, chosen on the basis of fewest cas9 integrations by South-
ern blotting, was chosen for further phenotypic analysis and use.
We first tested growth rate by spotting conidia of each strain
onto GMM plates and incubating for 72 h at 37°C. As shown in
Fig. 3B, the colony diameters of the cas9-hph strains were indis-
tinguishable from those of their respective wild-type controls at
each time point, indicating that growth rate was unaffected by cas9
expression. The amount of conidia produced by the cas9-hph
strains was also identical to that of the wild type, suggesting that
asexual development was also unaffected (see Fig. S3 in the sup-
plemental material).
To broadly assess the impact of cas9 expression on stress resis-
tance and cellular homeostasis, we tested the sensitivity of the
cas9-hph strains against a panel of stressing agents. Included in the
analysis were hydrogen peroxide, which induces oxidative stress
through the induction of hydroxyl radicals (35), Congo red, which
perturbs the cell wall by binding polysaccharide fibrils (36), and
fungin (a polyene) and voriconazole, which affect cell membrane
homeostasis either by binding ergosterol in the membrane or by
inhibiting its synthesis, respectively (37). In all cases, the sensitiv-
ity of the cas9-hph strain was identical to that of its respective
wild-type strain, suggesting that homeostasis in response to these
stresses is not affected by the expression of cas9 (Fig. 3C).
Finally, the virulence of the strains was tested in a murine
model of invasive aspergillosis. Briefly, groups of CD-1 outbred
mice were immunosuppressed with the synthetic corticosteroid
triamcinolone acetonide and then subsequently inoculated intra-
nasally with the indicated strains. Whereas the animal survival
curves are different in the Af293 and CEA10 backgrounds, the
cas9-hph strains were statistically indistinguishable from their re-
spective wild-type controls (Fig. 3D).
In summary, constitutive expression of the cas9 endonuclease
does not alter growth, development, stress resistance, and, impor-
tantly, virulence in either the Af293 or CEA10 background of A.
fumigatus under the tested conditions.
The cas9-hph strains as recipients for gRNA transformation.
FIG 2 Disruption of pksP using CRISPR/Cas. (A) Scheme of the transforma-
tion construct used for transformation into Af293 protoplasts. Transcriptional
promoter (P) and terminator (T) elements are noted. (B) Hygromycin-resis-
tant transformants were incubated on GMM to assess their pigmentation phe-
notype. Representative transformants are shown. Albino colonies resemble the
pksP control; nonalbino colonies resemble the wild type. (C) Phenotypic
ratios of the transformants.
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We next assessed whether the cas9-hph strains could serve as
recipients for a separate gRNA transformation. A plasmid that
contained both the pksP-gRNA (described above) and the bleR
cassette (bleomycin/phleomycin resistance) as a selectable
marker was constructed (Fig. 4). Linearized plasmid was intro-
duced into either the Af293 or CEA10 cas9-hph strain by chem-
ical transformation, and the phenotypes of the phleomycin-
resistant colonies were analyzed following incubation on
GMM. In the Af293 background, 19 out of 41 (46.3%) phleo-
mycin-resistant colonies displayed the albino phenotype,
whereas 16 out of 63 (25.4%) were albino in the CEA10 back-
ground (Fig. 4). Cumulatively, these data suggest that pksP
targeting via CRISPR/Cas is efficient in both the Af293 and
CEA10 backgrounds. Moreover, the cas9-hph strains can be
used as recipient strains for downstream gRNA transformation
and in this way may serve as universal strains for CRISPR-
mediated mutagenesis.
Genotypic analysis of the pksP locus in both albino and non-
albino transformants. The Cas9/gRNA complex is known to in-
duce double-strand breaks at the gRNA target sequence, which are
then resolved through error-prone NHEJ in the absence of a ho-
mologous sequence (24). To determine if the albino mutants ob-
tained in our experiments could be attributed to a similar mech-
anism, primers spanning the 5= end of the pksP coding sequence
were used to generate products (expected size, 1.5 kb), which were
then subjected to Sanger sequencing. The Af293 wild-type and
cas9-hph recipient strains were analyzed as controls, and both
were identical to the Af293 genomic reference at the pksP locus
(Fig. 5).
Two of the albino transformants in our analysis yielded a PCR
product of the expected size, the sequencing of which revealed that
either a single nucleotide insertion or deletion had occurred three
base pairs upstream of the targeted PAM site (Fig. 5, transfor-
mants 1 and 2). An in silico translation of the mutant sequences
FIG 3 Generation and analysis of constitutive cas9-expressing strains. (A) Top, scheme of the construct used for transformation into Af293 or CEA10 wild-type
protoplasts. Bottom, RT-PCR analysis confirming cas9 expression in the transformants. (B) Growth rate analysis. Conidia of the indicated strains were point inoculated
on GMM and incubated for 72 h at 37°C. Pictures, shown below the respective growth curve, were taken following the 72 h of incubation. (C) Stress sensitivity. Conidia
were point inoculated onto GMM plates containing increasing concentrations of the indicated drugs and incubated for 48 h at 37°C. (D) Virulence. Groups of 10 CD-1
mice were immunosuppressed with triamcinolone acetonide and inoculated intranasally with the indicated strains.
CRISPR in Aspergillus fumigatus
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predicted a frameshift that would ultimately lead to a premature
translational stop within 14 or 25 amino acids of the insertion or
deletion, respectively (data not shown). Thus, these single nucle-
otide indels are consistent with the CRISPR-mediated mutations
described in other systems (24).
Surprisingly, most albino colonies yielded amplicons that
were of a higher molecular weight than the 1.5 kb band of
wild-type, indicating perhaps that larger insertions had taken
place. For the single-construct transformation into wild-type,
sequencing of the amplicons indeed revealed that a portion of
the transforming PCR fragment had integrated at the expected
Cas9 cut site. More completely, the insertions included the 3=
end of the PCR fragment, extending variably into the structural
gRNA sequence (Fig. 5, transformants 3 and 4). Because non-
integrated (episomal) DNA is typically degraded in A. fumiga-
tus, these data suggested that both cas9 and the pksP-gRNA were
rapidly expressed within the protoplasts, allowing for the NHEJ
machinery to integrate part of the introduced DNA at the Cas9-
mediated double-strand break.
Similarly for the transformation of the cas9-hph recipient strains
(described in Fig. 4), four out of eight albino colonies yielded prod-
ucts of up to 6.5 kb larger than the expected size, suggesting that the
entire linearized plasmid had been inserted into the pksP locus (see
Fig. S4 in the supplemental material). This was confirmed, as se-
quencing of the high-molecular-weight bands (8 kb) all revealed
plasmid integration at the Cas9 cut site (data not shown).
We also analyzed several of the nonalbino transformants,
and all yielded sequences that were identical to the wild-type
reference (see Fig. S5 in the supplemental material). This sug-
gested that the nonalbino phenotype is most likely due to a lack
of targeting at the pksP locus, rather than an insertion/deletion
that yielded no functional alteration to PksP (e.g., a single
amino acid insertion).
Taken together, these data indicate that the albino phenotypes
observed in our transformants were due to the expected Cas9-
mediated cutting at the gRNA targeting sequence. The specific
NHEJ-mediated events at the cut site varied, however, ranging
from the single-nucleotide insertion/deletions, as observed in
other systems, to large insertions of transforming DNA con-
structs.
DISCUSSION
Gene replacement through homologous recombination can be im-
proved by several approaches in A. fumigatus. First, Krappman et
al. showed that by simply increasing the size of homologous
flanks in the transforming construct (directed toward abr2),
targeting efficiency could be increased from 0% (0.1-kb flanks)
to 10% (1 kb) to 22% (2 kb) (10). Though targeting could
presumably be increased with even larger flanking regions, the
cloning efficiency becomes the limiting factor; therefore, stan-
dard protocols typically involve flanking regions of approxi-
mately 1 kb on either side of the target gene. The second ap-
proach involves introduction of DNA into mutant strains of A.
fumigatus that are deficient in an essential component of the NHEJ
pathway. For example, in the same study, the replacement of abr2
with 0.1-kb flanks was increased to 75%, and with 2-kb flanks it
was increased to 95% in aakuA (ku70) mutant (10). Similarly, da
Silva Ferreira et al. demonstrated that pksP targeting could be
increased from 3% in a wild-type background to 85% in a akuB
(ku80) strain (9). Finally, Agrobacterium tumefaciens-mediated
transformation (ATMT) of A. fumigatus conidia has been found
to yield recombination rates of 35 to 66%, depending on the gene
(38, 39).
Unlike all of the above-mentioned strategies, the CRISPR/Cas9
system bypasses the need for homologous recombination alto-
gether, as the Cas9 nuclease is directed to its target through asso-
ciation with a short gRNA. In this study, we have demonstrated
the utility of this system in A. fumigatus by disrupting the pksP
gene with an efficiency of 25 to 53%. We propose that the system
functions in A. fumigatus as it does in other organisms, based on
two lines of evidence: (i) mutant phenotypes were observed only
upon introduction of both the cas9 gene and the gRNA, and (ii) pksP
disruption occurred at the expected Cas9 cut site in all albino mutants
tested. What is perhaps unique to our data, however, is the finding
that the transforming DNA can be integrated at the Cas9 cut site,
presumably through the NHEJ pathway. Indeed, this phenomenon
has recently been described in a mammalian cell CRISPR system (40).
However, to our knowledge, this is the first report of such construct
integrations among fungal CRISPRs. Why such a mechanism might
dominate (	50% of albino transformants tested) in A. fumigatus,
but not other fungi, remains unclear.
Importantly, we have demonstrated that the CRISPR/Cas9 system
works in two commonly employed strains of A. fumigatus, Af293
and CEA10. Although we did find different targeting ratios in the
two backgrounds in our experiment (46.3% for Af293 and 25.4%
for CEA10), we cannot yet state whether these differences would
hold up across multiple transformations or across different loci.
Nevertheless, the ability to introduce CRISPR/Cas9 constructs
into any A. fumigatus background represents a distinct advantage
of the system. In contrast, although targeting rates may be higher
in NHEJ mutants (up to 95%), researchers are confined to work
with strains in which akuA/akuB mutations have been generated.
The expression of heterologous enzymes has been known to alter
fungal physiology in unpredictable ways. In the dimorphic fungal
pathogenHistoplasma capsulatum, for example, the expression of
the hph selectable marker does not affect growth or develop-
ment but remarkably enhances virulence. This influence of
FIG 4 pksP targeting in cas9-hph recipient strains. A plasmid containing the
pksP gRNA sequence and the bleomycin resistance gene (bleR) was constructed
and introduced into Af293 and CEA10 cas9-hph recipient protoplasts. Phleo-
mycin-resistant colonies were incubated on GMM, and the proportion of al-
bino colonies was determined.
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HPH on virulence is dependent upon its phosphotransferase
activity, although the exact mechanism is unknown (41). Ac-
cordingly, we addressed concerns regarding the impact of the
Cas9 nuclease on A. fumigatus by generating strains that consti-
tutively express the cas9 gene. Importantly, we report that the
cas9-hph strains are identical to their wild-type controls with
respect to all tested phenotypes, including virulence in an im-
munosuppressed murine model. Thus, growth- and pathogen-
esis-related phenotypes associated with CRISPR/Cas-gener-
ated mutants can likely be attributed to the gene under study
rather than to unknown effects of the cas9 transgene. We pro-
pose that the cas9-hph strains we have generated could be im-
portant community resources for all downstream CRISPR-
based experiments for two reasons: (i) the large cas9 cassette
would not have to be cloned into the transformation con-
structs, thereby making gRNA construction more efficient and
high throughput, and (ii) a strain that expresses cas9 would
serve as a more appropriate reference strain (i.e., control) than
the standard wild type.
In summary, we have demonstrated that CRISPR/Cas9 can
be developed as a tool for high-efficiency gene disruption in A.
fumigatus. The further development of this technology (i.e.,
multigene targeting and recyclable cassettes for the reuse of
selectable markers) is under way and holds significant potential
for advancing the state of genetic research in this organism and,
consequently, an understanding of its pathogenesis.
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